From: ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma
Variable | ACTN1 (n) | ||
---|---|---|---|
Low (nā=ā41) | High (nā=ā116) | P-value | |
Age | |||
āā¤ 50āyears | 20 | 53 | 0.733 |
ā>ā 50āyears | 21 | 63 | |
Gender | |||
āFemale | 7 | 21 | 0.882 |
āMale | 34 | 95 | |
Hepatitis history | |||
āYes | 32 | 91 | 0.957 |
āNo | 9 | 25 | |
Gamma-glutamytransferase | |||
āā¤ 50(U/L) | 13 | 40 | 0.747 |
ā>ā 50(U/L) | 28 | 76 | |
*Alpha-fetoprotein | |||
āā¤ 20āng/mL | 19 | 27 | 0.005 |
ā>ā 20āng/mL | 22 | 89 | |
*Tumor thrombus | |||
āYes | 7 | 41 | 0.029 |
āNo | 34 | 75 | |
Tumor differentiation | |||
āI-II | 15 | 44 | 0.878 |
āIII | 26 | 72 | |
Vascular invasion | |||
āYes | 18 | 36 | 0.136 |
āNo | 23 | 80 | |
*Tumor size | |||
āā¤ 5ācm | 35 | 79 | 0.033 |
ā>ā 5ācm | 6 | 37 | |
*TNM stage | |||
āI-II | 33 | 73 | 0.039 |
āIII | 8 | 43 |